Wuhan KadWise Biotechnology Co., Ltd.
PrivateLast Round
Series C
Apr 7, 2026
Est. Valuation
$69.9M
Total Funding Raised
$101.36M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Wuhan KadWise Biotechnology Co., Ltd. is a biotechnology company that develops diagnostic and therapeutic solutions for gynecological cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Wuhan KadWise Biotechnology Co., Ltd. Comparables
Compare Wuhan KadWise Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shanghai Epiprobe Biotechnology Co., Ltd. | 87% | |
| Beijing OriginPoly Bio-Tec Co., Ltd. | 86% | |
| Guzip Biomarkers Corporation | 77% |
Wuhan KadWise Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 7, 2026 | ||||
| Series B | Dec 5, 2024 | ||||
| Series A | Jun 1, 2022 | ||||
| Pre Seed | Apr 1, 2019 |
Wuhan KadWise Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hongtai Capital Holdings | Series B |
| 招银国际金融有限公司 | Series C |
| Wuhan Hi-Tech Holding Group | Series B |
| 清控银杏创业投资管理（北京）有限公司 | Series C |
| Lengshanxi Capital | Series B |
| Hubei Provincial Science and Technology Investment Group | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 7, 2026
Raised $44M with participation from Zhaoyin International and Tsing Capital.
- Dec 5, 2024
$28M round led by Lengshanxi Capital.
Wuhan KadWise Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Wuhan KadWise Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is Wuhan KadWise Biotechnology Co., Ltd. a public or private company?
Wuhan KadWise Biotechnology Co., Ltd. is a private company.
What is the current stock price of Wuhan KadWise Biotechnology Co., Ltd.?
Wuhan KadWise Biotechnology Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Wuhan KadWise Biotechnology Co., Ltd. worth (valuation)?
Wuhan KadWise Biotechnology Co., Ltd.'s valuation is estimated at $69.9M based on funding round data.
Can I buy Wuhan KadWise Biotechnology Co., Ltd. stock?
Wuhan KadWise Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Wuhan KadWise Biotechnology Co., Ltd.'s last funding round?
Wuhan KadWise Biotechnology Co., Ltd.'s most recent funding round was Series C on December 5, 2024.
Who are the main investors in Wuhan KadWise Biotechnology Co., Ltd.?
Key investors in Wuhan KadWise Biotechnology Co., Ltd. include Lengshanxi Capital.
Will Wuhan KadWise Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for Wuhan KadWise Biotechnology Co., Ltd..
How can I track Wuhan KadWise Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Wuhan KadWise Biotechnology Co., Ltd.'s secondary market activity and sign up for updates.